oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes | NEJM The impact of oral semaglutide
Description
The influx of investment in the obesity sector is propelling the advancement of potentially next-generation obesity pharmaceuticals, uncovering novel mechanisms of action, formulating oral alternatives to injectables, and aiming to alleviate patient burden by reducing administration frequency [76]
If moving from retatrutide to a lower-potency medication for maintenance, the reduced appetite suppression makes it easier to consume adequate protein, which naturally supports lean tissue recovery
By slowing down digestion and reducing cravings, weekly GLP-1 injections help you feel full sooner and eat less, supporting steady weight loss when combined with healthy diet and exercise
The third receptor in Retatrutides triple agonist mechanism, responsible for thermogenesis effects
